Litigation

Forget Fair; It's Litigation As Usual

Posted on November 19, 2007
Today's (11.17.07) New York Times article by Joe Nocera "Forget Fair; It's Litigation As Usual," explores the world of mass tort litigation. Nocera is no friend of the everyman and is cynical about private lawyers policing big pharmaceutical companies in the form of "mass tort" actions...

TIA... This is (My) Africa

Posted on November 15, 2007
UPDATE: Well, the pictures are finally in. They're scattered through out this entry, so please check them out. For a larger view, just click the picture. The words Leo DeCaprio spoke in Blood Diamond ring in my head.  My friends all tell me to be safe...

Merck Agreement to Resolve U.S. VIOXX® Product Liability Lawsuits

Posted on November 09, 2007
Big news hit this morning as VIOXX manufacturer, Merck agreed to resolve 95% of the outstanding VIOXX claims with a $4.85 BILLION settlement fund.  The fund will be established and victims will be evaluated on a case-by-case basis, with varying amounts being paid from the fund...

Merck to Pay $4.85 Billion To Settle Most Vioxx Cases

Posted on November 09, 2007
In a very significant announcement today, Merck has released that it will agree to pay about $4.85 billion to settle a significant portion of the 27,000 cases against it's painkiller Vioxx. A Wallstreet Journal article is below. Not everyone is eligible and we are working on analyzing the proposal and how it applies...

To access this complete feed in the blog feed reader login or register for free.

Trasylol Pulled from U.S. Market

Posted on November 05, 2007
For almost two years, Trasylol, a drug used to prevent blood loss during surgery was under scrutiny by the FDA.  In fact, on February, 2006, the FDA issued a Public Health Advisory warning doctors who perform heart bypass surgery and their patients that Trasylol (generic name aprotinin) was linked in two scientific studies to severe side effects, including kidney problems, heart attacks and strokes in patients undergoing artery bypass graft surgery...

Tire Recalls

Posted on November 01, 2007
Today’s Wall Street Journal cites the dangers of tire recalls.  Consumers need to know that just because you go to the dealership and discover that your specific serial number tires haven't been recalled, you should consider changing them anyway...

Want To Go To Law School?

Posted on October 31, 2007
It appears that all is not lost on the law school front.  As a follow-up to my article about why there are no University of Houston law graduates at Cravath, Swain & Moore, I wanted to pass along a recent Wall Street Journal article.  The article contains some great advice for folks considering what law school to attend...

Safety vs. Savings on Consumer Products

Posted on October 30, 2007
One of my previous blog articles reported on the safety hazards of toys manufactured in China.  Now, Congress is finally perking up its ears and evaluating the inefficacy and inefficiency of the Consumer Product Safety Commission in regard to the safety of imported goods...

Too Many Followers, Not Enough Leaders.

Posted on October 30, 2007
On Monday, October 30th, I had the distinct honor and privilege of speaking at the Greater Dallas Hispanic Chamber of Commerce Golf Tournament.  There are some who would consider the content of this speech as liberal, while others would view it as conservative, depending on which side of the fence you’re on...

Medtronic Defibrillator Recalled

Posted on October 30, 2007
In its October 30th, ’07 issue, the Wall Street Journal reported that the Sprint Fidelis 6949 defibrillator, manufactured by Medtronic, Inc. has been recalled.  Defibrillators are implanted devices that treat cardiac arrest and restore normal heart rhythm...

FDA Update On Trasylol

Posted on October 26, 2007
On Thursday, October 25th, the Food and Drug Administration (FDA) stated that Trasylol, a drug used during heart bypass surgery to prevent severe bleeding, increases the risk of death as compared to other drugs.The FDA’s announcement was based on a Canadian study that compared Trasylol’s effectiveness and safety with two other drugs...

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.